5,N-dimethyl-N-isopropyltryptamine

5,N-dimethyl-N-isopropyltryptamine

drugbox
IUPAC_name = isopropyl-(2-(1H-indol-3-yl)-ethyl)-methylamine



width = 140
CAS_number =
ATC_prefix =
ATC_suffix =
PubChem =
C=15 | H=22 | N=2
molecular_weight = 230.36 g/mol
smiles =
melting_point =
melting_high =
bioavailability =
protein_bound =
metabolism =
elimination_half-life =
excretion =
pregnancy_AU =
pregnancy_US =
pregnancy_category =
legal_AU =
legal_CA =
legal_UK =
legal_US =
legal_status =
routes_of_administration =

5,N-dimethyl-N-isopropyltryptamine (5-Me-MIPT) is a tryptamine derivative that is thought to be a hallucinogenic drug. It was first made in 1989. "In vitro" binding experiments on brain homogenates showed it to have a binding affinity between that of MIPT and 5-MeO-MIPT, [ McKenna DJ, Repke DB, Peroutka SJ Neuropharmacology 29:193-198 (1989) ] both of which are known to be active hallucinogens in humans.

References


Wikimedia Foundation. 2010.

Игры ⚽ Поможем решить контрольную работу

Look at other dictionaries:

  • Designer drug — Not to be confused with Drug design. Designer drug is a term used to describe drugs that are created (or marketed, if they had already existed) to get around existing drug laws, usually by preparing analogs or derivatives of existing drugs by… …   Wikipedia

Share the article and excerpts

Direct link
Do a right-click on the link above
and select “Copy Link”